GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-46 Cr | ₹8.71 Cr | ₹808 Cr | ₹-406 Cr | ₹418 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-46 Cr |
| Mar2024 | ₹8.71 Cr |
| Mar2023 | ₹808 Cr |
| Mar2022 | ₹-406 Cr |
| Mar2021 | ₹418 Cr |
How is Cash Flow from Investing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-46 Cr | Negative | |
| Mar2024 | ₹8.71 Cr | -98.92 | |
| Mar2023 | ₹808 Cr | Positive | |
| Mar2022 | ₹-406 Cr | Negative | |
| Mar2021 | ₹418 Cr | - | |
Compare Cash Flow from Investing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹40,761.9 Cr | 2.2% | -3.2% | -6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.2% |
-3.2% |
-6.5% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses